Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
34.05
-0.64 (-1.84%)
At close: Sep 9, 2026, 4:00 PM EDT
34.13
+0.08 (0.23%)
After-hours: Sep 9, 2026, 6:24 PM EDT
Medline Revenue
Medline had revenue of $7.69B in the quarter ending June 27, 2026, with 11.60% growth. This brings the company's revenue in the last twelve months to $29.94B, up 12.12% year-over-year. In the year 2025, Medline had annual revenue of $28.43B with 11.47% growth.
Revenue (ttm)
$29.94B
Revenue Growth
+12.12%
P/S Ratio
1.51
Revenue / Employee
$665,311
Employees
45,000
Market Cap
44.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.43B | 2.93B | 11.47% |
| Dec 31, 2024 | 25.51B | 2.28B | 9.80% |
| Dec 31, 2023 | 23.23B | 1.78B | 8.31% |
| Dec 31, 2022 | 21.45B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
MDLN News
- 6 days ago - Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 7 days ago - Kaplan Fox Notifies Medline Inc. (MDLN) Investors of a Securities Investigation into the Company - Newsfile Corp
- 16 days ago - Kaplan Fox Announces a Securities Investigation into Medline Inc. (MDLN) - Investors Encouraged to Contact the Firm - Newsfile Corp
- 19 days ago - Kaplan Fox Encourages Investors of Medline Inc. (MDLN) to Contact the Firm to Learn About Their Legal Rights - Newsfile Corp
- 21 days ago - Kaplan Fox is Investigating Medline Inc. (MDLN) for Potential Violations of the Federal Securities Laws - Newsfile Corp
- 23 days ago - Medline price target lowered to $46 from $53 at JPMorgan - TheFly
- 4 weeks ago - Medline price target lowered to $55 from $62 at Tigress Financial - TheFly
- 4 weeks ago - Medline price target lowered to $45 from $53 at TD Cowen - TheFly